Related Experiment Video
Updated: Aug 10, 2026

Functional Assessment of Intestinal Motility and Gut Wall Inflammation in Rodents: Analyses in a Standardized Model of Intestinal Manipulation
Published on: September 11, 2012
Stability of irritable bowel syndrome using a Rome II-based classification
R E Williams1, C L Black, H-Y Kim
1Worldwide Epidemiology, Glaxo SmithKline, Research Triangle Park, NC 27709, USA. rachel.e.williams@gsk.com
Irritable Bowel Syndrome (IBS) diagnosis using symptom criteria is unstable over time. Many individuals no longer meet IBS criteria after two years, highlighting the episodic nature of the condition.
Area of Science:
- Gastroenterology
- Clinical Epidemiology
Background:
- Irritable Bowel Syndrome (IBS) diagnosis relies on symptom-based criteria due to the absence of a biological marker.
- The Rome II criteria are commonly used for IBS classification.
Purpose of the Study:
- To assess the stability of self-reported symptoms used for Irritable Bowel Syndrome (IBS) classification based on Rome II criteria.
- To evaluate how consistently individuals meet IBS diagnostic criteria over a two-year period.
Main Methods:
- A population-based cohort identified with modified Rome II criteria in 2001 was re-evaluated two years later.
- Data collection utilized a web-based questionnaire to assess current symptoms and IBS classification.
Main Results:
- Only 30% of subjects maintained the same IBS subtype, while 52% no longer met IBS criteria at follow-up.
- Individuals remaining symptomatic were more likely to have the alternating IBS subtype, higher psychological impairment, and lower quality of life.
- Absence of pain was a key factor for subjects no longer meeting IBS criteria, though many still reported moderate abdominal pain.
Conclusions:
- Irritable Bowel Syndrome (IBS) is characterized by its episodic nature, with significant fluctuations in symptom presentation over time.
- Current symptom-based classification systems, including Rome II criteria, have limitations in capturing the dynamic course of IBS.
More Related Videos
Related Concept Videos
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Drugs for Treatment of Constipation-Predominant IBS
Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Irritable Bowel Syndrome III: Medical and Nursing Management
Irritable Bowel Syndrome

